Product Description
| Cat Number | PP-320 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Blocks MYC activation |
| Modification | D arginine at position 1, ornithine at position 6 and beta alanine at position 10 |
| Purity | >95% by hplc |
| Biomarker Target | Nuclear receptor modulators,Protein-protein interactions |
| Sequence Three Letter Code | H-(D)Arg-Lys-Lys-Arg-Arg-Orn-Arg-Arg-Arg-βAla-Leu-Ser-Ser-Ile-Leu-Gln-Gly-Leu-Tyr-Gln-Leu-Asp-Thr-OH |
| Molecular Formula | C121H218N46O32 |
| Sl Sequence | rKKRR-Orn-RRR-βAla-LSSILQGLYQLDT |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Shimoda et al (2021) KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth. Commun Biol. 4(1) 1330 PMID: 34857874 Related areasAll peptides >All protein-protein interaction modulators >All nuclear receptor modulators >All cancer research categories > |
| Note | The product is for research use only |
Share Item: